Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Multiple Sclerosis peptide trials
9 selected ClinicalTrials.gov records carrying the official condition label Multiple Sclerosis. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
9 selected records.
1 profiles.
2012–2021 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 25 selected PubMed records and 11 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Multiple Sclerosis unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT00176592
PeptideScanner retained ClinicalTrials.gov record NCT00176592 at 2026-11-16T17:42:50.457Z. Its registry update date was 2021-11-16, and PeptideScanner's reviewed identity mapping was glatiramer-acetate.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- November 16, 2021
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT00239993
PeptideScanner retained ClinicalTrials.gov record NCT00239993 at 2026-11-16T17:42:50.457Z. Its registry update date was 2017-02-06, and PeptideScanner's reviewed identity mapping was glatiramer-acetate.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- February 6, 2017
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT00475865
PeptideScanner retained ClinicalTrials.gov record NCT00475865 at 2026-11-16T17:42:50.457Z. Its registry update date was 2012-11-06, and PeptideScanner's reviewed identity mapping was glatiramer-acetate.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- November 6, 2012
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Glatiramer acetate · 2021-12-09
ClinicalTrials.gov record NCT02499900
Completed at the retained observation.
Open attributed record →Glatiramer acetate · 2021-11-16
ClinicalTrials.gov record NCT00176592
Completed at the retained observation.
Open attributed record →Glatiramer acetate · 2021-03-19
ClinicalTrials.gov record NCT00937157
Completed at the retained observation.
Open attributed record →Glatiramer acetate · 2018-06-08
ClinicalTrials.gov record NCT01569451
Completed at the retained observation.
Open attributed record →Glatiramer acetate · 2017-02-06
ClinicalTrials.gov record NCT00239993
Completed at the retained observation.
Open attributed record →Glatiramer acetate · 2013-10-17
ClinicalTrials.gov record NCT01167426
Completed at the retained observation.
Open attributed record →Glatiramer acetate · 2012-12-31
ClinicalTrials.gov record NCT00811395
Completed at the retained observation.
Open attributed record →Glatiramer acetate · 2012-11-06
ClinicalTrials.gov record NCT00475865
Completed at the retained observation.
Open attributed record →Glatiramer acetate · 2012-06-25
ClinicalTrials.gov record NCT00666224
Completed at the retained observation.
Open attributed record →